BATH ROW MEDICAL PRACTICE
FIRST FLOOR, COLSTON SUITE, ATTWOOD GREENN HC, 30 BATH ROW, EDGBASTON, BIRMINGHAMCKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 48 | 77 | 62.3% | |
CKD 4 | 2008 | 54 | 68 | 79.4% | |
CKD 5 | 2009 | 9 | 9 | 100.0% | |
CKD 5 | 2010 | 10 | 11 | 90.9% | |
CKD 5 | 2011 | 11 | 11 | 100.0% | |
CKD 5 | 2012 | 9 | 11 | 81.8% | |
CKD 5 | 2013 | 13 | 14 | 92.9% | |
CKD003 | 2014 | 15 | 17 | 88.2% | |
CKD003 | 2015 | 15 | 18 | 83.3% | |
NM84 | 2016 | 11 | 22 | 50.0% | |
NM84 | 2017 | 8 | 16 | 50.0% | |
NM84 | 2018 | 9 | 15 | 60.0% | |
NM84 | 2019 | 9 | 16 | 56.2% | |
NM84 | 2020 | 10 | 17 | 58.8% | |
NM84 | 2022 | 9 | 15 | 60.0% | |
NM84 | 2023 | 9 | 14 | 64.3% |